Indian Journal of Nuclear Medicine

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 34  |  Issue : 1  |  Page : 14--18

Molecular imaging to the surgeons rescue: Gallium-68 DOTA-exendin-4 positron emission tomography-computed tomography in pre-operative localization of insulinomas


UN Pallavi1, Vindhya Malasani1, Ishita Sen1, Parul Thakral1, Sugandha Dureja1, Vineet Pant1, Vinay Samuel Gaikwad2, Arvind Sabharwal3 
1 Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, Haryana, India
2 Department of Surgical Oncology, Paras Hospitals, Gurgaon, Haryana, India
3 Department of Paediatric Oncology, Fortis Memorial Research Institute, Gurgaon, Haryana, India

Correspondence Address:
Dr. Ishita Sen
Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, Haryana
India

Background: Insulinoma is an islet-cell neoplasm that secretes insulin. It is usually localized to the pancreas and is often the most common cause of endogenous hyperinsulinemic hypoglycaemia in non-diabetic adult patients. Surgical excision with a curative intent is the standard modality of treatment, and it requires precise localization of tumor tissue. Ga-68 DOTA-exendin-4 PET/CT scan is a clinically reasonable and sensitive scan for the identification of insulinoma. The aim of this prospective cohort study was to determine the overall accuracy of Ga-68 DOTA-exendin-4 PET/CT scan in the detection of insulinoma. Materials and Methods: Eight patients with fasting hyperinsulinemic hypoglycaemia with neuroglycopenic symptoms were enrolled in this study which was conducted during October 2016 to October 2017. Whole body PET/CT scan was performed on a Philips time of flight PET/CT scanner, 60 minutes after injection of Ga-68 DOTA-exendin-4 (and also Ga-68 DOTANOC). The imaging findings were compared to the histopathological diagnosis in six out of eight patients and to subsequent follow up in the remaining two patients who did not undergo surgery. Results: The sensitivity of Ga-68 DOTA-Exendin-4 PET/CT scan in insulinoma detection was found to be 75%. Conclusion: Ga-68 DOTA-Exendin-4 PET/CT scan is highly sensitive for identification and exact localization of insulinoma which can guide better surgical exploration. However, randomised controlled trials are needed to assess the accuracy of Ga-68 DOTA-Exendin PET/CT scan in localization of insulinoma.


How to cite this article:
Pallavi U N, Malasani V, Sen I, Thakral P, Dureja S, Pant V, Gaikwad VS, Sabharwal A. Molecular imaging to the surgeons rescue: Gallium-68 DOTA-exendin-4 positron emission tomography-computed tomography in pre-operative localization of insulinomas.Indian J Nucl Med 2019;34:14-18


How to cite this URL:
Pallavi U N, Malasani V, Sen I, Thakral P, Dureja S, Pant V, Gaikwad VS, Sabharwal A. Molecular imaging to the surgeons rescue: Gallium-68 DOTA-exendin-4 positron emission tomography-computed tomography in pre-operative localization of insulinomas. Indian J Nucl Med [serial online] 2019 [cited 2019 Apr 24 ];34:14-18
Available from: http://www.ijnm.in/article.asp?issn=0972-3919;year=2019;volume=34;issue=1;spage=14;epage=18;aulast=Pallavi;type=0